Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Wentao Luo
Observed name:
Luo, Wentao
Institutions:
Hubei University of Medicine,
Chongqing University,
Chongqing Industry Polytechnic University
Observed institutions:
Tongji University,
Hubei University of Medicine,
Chongqing University,
Meizhou City People's Hospital,
Shanghai Tenth People's Hospital,
Dongfeng General Hospital,
Chongqing Industry Polytechnic University,
Southeast University
show all 8
ORCID:
0009-0002-8549-2480
Observed ORCIDs:
0009-0002-8549-2480,
0009-0007-0655-5436
OpenAlex ID:
A5078984755
Microstructure and mechanical properties of a 2 wt% Nb bearing low carbon steel
2021
·
Wentao Luo
, Lingli Wang
, et al.
·
Materials Science and Engineering A
·
20
The Origin of Enhanced Room Temperature Ferromagnetism in Ba Doped BiFeO3
2013
·
Lirong Luo
, Wentao Luo
, et al.
·
Journal of Superconductivity and Novel Magnetism
·
16
Metagenomic Next-Generation Sequencing for Accurate Diagnosis of Pneumocystis jirovecii Pneumonia: A Comparative Study with Traditional Methods
2024
·
Wentao Luo
, Xiuwen Lin
, et al.
·
Infection and Drug Resistance
·
7
Prognostic value of lncRNA LINC01018 in prostate cancer by regulating miR-182-5p (The role of LINC01018 in prostate cancer)
2023
·
Wentao Luo
, Tingting Li
, et al.
·
Nucleosides Nucleotides & Nucleic Acids
·
6
The 30-min diaphragm movement change rate for predicting weaning success in severe pneumonia patients requiring invasive ventilation
2025
·
Wentao Luo
, Huagen Zhang
, et al.
·
Frontiers in Medicine
·
5
PDF
Hot-Deformation Behavior and Processing Maps of a Low-Carbon Fe-2 wt% Nb Steel
2021
·
Wentao Luo
, Pengzhan Cai
, et al.
·
Metals
·
4
PDF
NUF2 activated by YY1 promotes prostate cancer malignancy via p38/MAPK signaling axis and serves as a therapeutic target
2025
·
Chengqi Jin
, Jing Xu
, et al.
·
Biochemical Pharmacology
·
3
Hsa_circ_0070440 mediates the prognosis and progress of human prostate cancer.
2025
·
Min Huang
, Junming Zhang
, et al.
·
PubMed
·
2
Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in De Novo Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
2025
·
Ruiliang Wang
, Jing Xu
, et al.
·
Cancer Research Communications
·
1
PDF
Emotional stress: a prominent factor positively related to the onset and recurrence of bladder cancer as revealed by NHANES and a Chinese database
2025
·
Wentao Luo
, Yifei Chen
, et al.
·
Annals of Medicine
·
1
Microstructure evolution and quantitative analysis of mechanical properties of cold-rolled low carbon niobium steel
2024
·
Wentao Luo
·
Metallurgical Research & Technology
·
1
Improving microstructural homogeneity of high-purity ta plates via circumferentially rotated dynamic offsets and shear force adjustment rolling
2026
·
Li Wang
, Wentao Luo
, et al.
·
Materials Letters
Biological Age Acceleration as a Marker of Chronic Kidney Disease: A Population-Based Study
2026
·
Quan Zhou
, Mingcheng Chen
, et al.
·
Research Square
PDF
The influence of Fe 2 Nb on the microstructure and mechanical properties of hot-rolled low carbon niobium steel
2026
·
Wentao Luo
·
Metallurgical Research & Technology
Internal Partial Discharge Detection of Stator Winding of Hydro-Generator Using a Planar Ultrawideband Monopole Antenna
2026
·
Jianlin Hu
, Hongfei Deng
, et al.
·
IEEE Transactions on Instrumentation and Measurement
Supplementary Table S3 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in De Novo Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
2025
·
Ruiliang Wang
, Jing Xu
, et al.
Supplementary Table S2 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in De Novo Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
2025
·
Ruiliang Wang
, Jing Xu
, et al.
Supplementary Table S1 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in De Novo Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
2025
·
Ruiliang Wang
, Jing Xu
, et al.
Table 1 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in De Novo Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
2025
·
Ruiliang Wang
, Jing Xu
, et al.
Supplementary Table S5 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in De Novo Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
2025
·
Ruiliang Wang
, Jing Xu
, et al.
Supplementary Table S4 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in De Novo Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
2025
·
Ruiliang Wang
, Jing Xu
, et al.
Data from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in De Novo Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
2025
·
Ruiliang Wang
, Jing Xu
, et al.
Supplementary Figure S2 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in De Novo Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
2025
·
Ruiliang Wang
, Jing Xu
, et al.
Figure 1 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in De Novo Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
2025
·
Ruiliang Wang
, Jing Xu
, et al.
Supplementary Figure S4 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in De Novo Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study
2025
·
Ruiliang Wang
, Jing Xu
, et al.
Show more works
View as search
Works count:
33
Citation count:
66
H-index:
5
I10-index:
2
Year
Topic
Type